The chemical substance known as (S)-(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone hydrochloride, with the CAS number 2065147-70-6, is a synthetic compound characterized by its complex structure, which includes an azetidine ring, a piperidine moiety, and a trifluorophenyl group. This compound exhibits a chiral center, indicating that it exists in two enantiomeric forms, with the (S)-configuration being biologically relevant. The presence of the hydroxyl group contributes to its potential as a hydrogen bond donor, while the trifluorophenyl group enhances lipophilicity and may influence its pharmacological properties. As a hydrochloride salt, it is likely to be more soluble in water, facilitating its use in biological studies or pharmaceutical applications. The compound's unique structural features suggest potential activity in medicinal chemistry, particularly in the development of therapeutics targeting specific biological pathways. Further studies would be necessary to elucidate its mechanism of action and therapeutic efficacy.

(S)-(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone HCL

2065147-70-6: The chemical substance known as (S)-(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone hydrochloride, with the CAS number 2065147-70-6, is a synthetic compound characterized by its complex structure, which includes an azetidine ring, a piperidine moiety, and a trifluorophenyl group. This compound exhibits a chiral center, indicating that it exists in two enantiomeric forms, with the (S)-configuration being biologically relevant. The presence of the hydroxyl group contributes to its potential as a hydrogen bond donor, while the trifluorophenyl group enhances lipophilicity and may influence its pharmacological properties. As a hydrochloride salt, it is likely to be more soluble in water, facilitating its use in biological studies or pharmaceutical applications. The compound's unique structural features suggest potential activity in medicinal chemistry, particularly in the development of therapeutics targeting specific biological pathways. Further studies would be necessary to elucidate its mechanism of action and therapeutic efficacy.

CAS 2065147-70-6

(S)-(3-hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone HCL

[3-hydroxy-3-[(2S)-2-piperidyl]azetidin-1-yl]-(2,3,4-trifluorophenyl)methanone;hydrochloride

Ref: IN-DA01JUD0

Cobimetinib Impurity 1

Ref: 4Z-C-300003

(S)-(3-Hydroxy-3-(piperidin-2-yl)azetidin-1-yl)(2,3,4-trifluorophenyl)methanone hydrochloride

Ref: 10-F618752